Do you want to read an article? Please log in or register.
One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation
Macular DiseasesRetinal Diseases
Related content
Macular Diseases
Age-related macular degeneration-associated peripapillary choroidal neovascularization in the era of anti-vascular endothelial growth factor therapy
Retina.
Lin T, Dans K, Meshi A, Muftuoglu IK, Amador-Patarroyo MJ, Chen KC, Cheng L, Freeman WR
doi: 10.1097/IAE.
Retinal Diseases
Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study
Eur J Ophthalmol.
Furino C, Di Antonio L, Grassi MO, Rispoli M, Reibaldi M, Niro A, Alessio G
doi: 10.1177/1120672118792187.
Macular Diseases
Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology
Ophthalmology.
Bakri SJ, Thorne JE, Ho AC, Ehlers JP, Schoenberger SD, Yeh S, Kim SJ
doi: 10.1016/j.ophtha.2018.07.028.
Retinal Diseases
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens
Br J Ophthalmol.
Invernizzi A, Pichi F, Symes R, Zagora S, Agarwal AK, Nguyen P, Erba S, Xhepa A, De Simone L, Cimino L, Gillies MC, McCluskey PJ
doi: 10.1136/bjophthalmol-2019-315257.
Macular Diseases
Characterisation of poor visual outcomes of neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents
Ophthalmology.
Nguyen CL, Gillies MC, Nguyen V, Daien V, Cohn A, Banerjee G, Arnold J; Fight Retinal Blindness! Study Group
doi: 10.1016/j.ophtha.2018.11.036.
Macular Diseases
Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial
Ophthalmology.
Bailey C, Scott LJ, Rogers CA, Reeves BC, Hamill B, Peto T, Chakravarthy U, Harding SP, writing committee for the IVAN Study Group
doi: 10.1016/j.ophtha.
COMMENTED
Macular Diseases
Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
JAMA Ophthalmol.
Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ,
Iezzi R
doi: 10.1001/jamaophthalmol.
COMMENTED
Macular Diseases
Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
★ 3
Recommended by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
JAMA Ophthalmol
Fu DJ, Keenan TD, Faes L, Lim E, Wagner SK, Moraes G, Huemer J, Kern C, Patel PJ, Balaskas K, Sim DA, Bunce C, Stratton I, Keane PA
doi: 10.1001/jamaophthalmol.2020.5044
Macular Diseases
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial
JAMA Ophthalmol.
Bressler SB, Odia I, Maguire MG, Dhoot DS, Glassman AR, Jampol LM, Marcus DM, Solomon SD, Sun JK; Diabetic Retinopathy Clinical Research Network
doi: 10.1001/jamaophthalmol.